Sarbecovirus ORF6 proteins hamper induction of interferon signaling

Izumi Kimura1, Yoriyuki Konno1, Keiya Uriu2

  • 1Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 1088639, Japan.

Cell Reports
|March 25, 2021
PubMed

Insights

The SARS-CoV-2 ORF6 protein inhibits innate immune signaling, including interferon production. This viral protein is a more potent immune antagonist than its SARS-CoV counterpart, contributing to COVID-19 pathogenesis.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Sarbecoviruses, including SARS-CoV and SARS-CoV-2, possess a unique ORF6 gene.
  • Innate immunity, particularly interferon (IFN) responses, is crucial for controlling viral infections.
  • Dysregulation of innate immunity is implicated in severe COVID-19 outcomes.

Purpose of the Study:

  • To investigate the role of the ORF6 gene in innate immune evasion by SARS-CoV-2.
  • To compare the immune antagonistic activity of ORF6 from SARS-CoV-2 and SARS-CoV.
  • To identify key viral determinants and mechanisms underlying ORF6-mediated immune suppression.

Main Methods:

  • In vitro assays to assess IFN induction and signaling pathways.
  • Mutational analysis of SARS-CoV-2 ORF6 to identify critical residues.
  • Analysis of ORF6 C-terminal region function and IRF3 nuclear translocation.
  • Bioinformatic analysis of SARS-CoV-2 isolates for ORF6 genetic variations.

Main Results:

  • SARS-CoV-2 ORF6 significantly inhibits type I and III IFN induction and signaling.
  • SARS-CoV-2 ORF6 is a more potent inhibitor of innate immunity than SARS-CoV ORF6.
  • Specific residues (E46, Q56) and the C-terminal region of ORF6 are critical for its antagonistic activity.
  • ORF6 inhibits the nuclear translocation of IRF3, a key transcription factor for IFN production.
  • Inactivating mutations in ORF6 were found in a small percentage of SARS-CoV-2 isolates.

Conclusions:

  • The ORF6 protein is a key viral factor contributing to SARS-CoV-2's ability to evade innate immune responses.
  • Differences in ORF6 function between SARS-CoV-2 and SARS-CoV may influence viral pathogenesis.
  • Understanding ORF6's mechanism of immune suppression provides insights into COVID-19 pathogenesis and potential therapeutic targets.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.4K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.5K